140 filings
Page 4 of 7
8-K
tafnnck5 wewtyuon24
5 Aug 19
Studies highlight antimicrobial activity for AC5 technology platform; AC5™ Topical Hemostat1 under Review by Notified Body
8:02am
8-K
xpz1rb y7y
13 May 19
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
7:59am
8-K
ukfda2nv
24 Apr 19
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
7:59am
8-K
df44vr1
17 Dec 18
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5TM Topical Gel
8:07am
8-K
hmy9ga c4
6 Dec 18
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
7:57am
8-K
1wnz9a2
4 Dec 18
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
7:53am
8-K
hihd0e0
28 Nov 18
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
8:00am
8-K
fquta2o
26 Nov 18
Company to provide regulatory filing status update
9:05am
8-K
c5hf2u kzs72el1ct7cg
1 Oct 18
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5™ Topical Gel
12:00am
8-K
pwd8m837
5 Sep 18
Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5
12:00am
8-K
g2hva0q9hqqyue0
20 Jul 18
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
7:38am
8-K
qack1co
29 Jun 18
Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering
8:16am
8-K
1fjgdk
26 Jun 18
Arch Therapeutics Provides Skin Sensitization Study Status Update
7:55am
8-K
9toiw0enb83sfknusncx
15 Jun 18
Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
12:00am
8-K
xoslwdxoe1uxcw74
8 May 18
Regulation FD Disclosure
7:56am
8-K
omegoqm yu6sp3pvn
12 Mar 18
Regulation FD Disclosure
12:00am
8-K
jj9acohgef0
5 Feb 18
Regulation FD Disclosure
12:00am
8-K
ck8fxmnxf3j5xj 721c
18 Dec 17
Regulation FD Disclosure
12:00am
8-K
5rsv1g7a 8kul
12 Sep 17
Regulation FD Disclosure
12:00am
8-K
je3zg ok0drv
25 Jul 17
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5™ Topical Gel
12:00am